Browsing Tag
Co-Diagnostics
7 posts
Co-Diagnostics (NASDAQ: CODX) secures Australian patent for Co-Dx PCR platform technologies
Co-Diagnostics lands its first patent for the Co-Dx PCR platform in Australia. Find out what it means for global expansion and diagnostic disruption.
Co-Diagnostics (Nasdaq: CODX) launches clinical trial for multiplex respiratory test as FDA approval push begins
Co-Diagnostics launches trial for flu, COVID-19, RSV test kit targeting FDA clearance. Learn how it plans to lead in decentralized respiratory diagnostics.
Inside Co-Diagnostics’ Saudi Arabia expansion: the CoMira JV bringing PCR manufacturing to the MENA region
Find out how Co-Diagnostics’ joint venture with Arabian Eagle is localizing its Co-Dx PCR platform through CoMira Diagnostics to transform Middle East testing access.
Co-Diagnostics revamps COVID-19 test for FDA clearance amid stability concerns
Co-Diagnostics, Inc. has announced that it is withdrawing its 510(k) clearance application for its Co-Dx PCR COVID-19 test…
Co-Diagnostics seeks FDA clearance for COVID-19 Test and diagnostic instrument
Co-Diagnostics, Inc. (Nasdaq: CODX), a pioneering molecular diagnostics company, has reached a pivotal milestone by completing its first…
CoSara Diagnostics gains CDSCO approval for Saragene COVID-19 2-gene multiplex RT-PCR test
CoSara Diagnostics, a prominent player in the field of molecular diagnostics, has achieved a significant milestone with the…
Novel coronavirus diagnostic test CoPrimer launched by Co-Diagnostics
Novel coronavirus diagnostic test : Co-Diagnostics, a US molecular diagnostics company, said that its research use only (RUO)…